斯克里普斯研究中心的科学家发现，LY2444296（一种阻断 kappa 阿片受体的化合物）可以减少依赖动物的饮酒量，可能为酒精使用障碍提供新的治疗选择。 Scripps Research scientists found that LY2444296, a compound blocking kappa opioid receptors, reduced alcohol consumption in dependent animals, potentially informing new treatment options for alcohol use disorder.

斯克里普斯研究中心的科学家在动物研究中发现，LY2444296（一种阻断 kappa 阿片受体 (KOP) 的化合物）可以减少酒精依赖情况下的饮酒量。 Scripps Research scientists discovered that LY2444296, a compound that blocks the kappa opioid receptor (KOP), may reduce alcohol consumption in cases of dependence in animal studies. 发表在《科学报告》上的研究结果表明，针对并阻断 KOP 系统可能会阻止酒精滥用，并为酒精使用障碍提供新的治疗选择。 The findings, published in Scientific Reports, suggest that targeting and blocking the KOP system could potentially stop alcohol abuse and inform new treatment options for alcohol use disorder.